Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02555644
Title A Study of LY2606368 With Chemotherapy and Radiation in Participants With Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Eli Lilly and Company
Indications

oropharynx cancer

head and neck squamous cell carcinoma

laryngeal squamous cell carcinoma

hypopharynx cancer

Therapies

Prexasertib

Cisplatin

Cetuximab

Age Groups: adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Medical Center Birmingham Alabama 35249 United States Details
University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
Centre Leon Berard Lyon 69008 France Details
Gustave Roussy Villejuif Cedex 94805 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field